Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Test conducted similar to OECD TG 401; no GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1981

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
: no control animal group
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Methyl chloroformate
EC Number:
201-187-3
EC Name:
Methyl chloroformate
Cas Number:
79-22-1
Molecular formula:
C2H3ClO2
IUPAC Name:
methyl chloroformate
Details on test material:
- Name of test material (as cited in study report): Methylchloroformiat (methyl chloroformate)
- Physical state: liquid
- Analytical purity: 99 %

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: HAGEMANN
- Weight at study initiation: female (160 - 200 g); male (170 - 260 g)
- Fasting period before study: 15-20 h
- Diet (e.g. ad libitum): Herilan MRH-Haltung; H . Eggersmann KG

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on oral exposure:
Concentration in vehicle: 43.00, 13.62, 9.28, 4.30, 2.94 % (w/v)
Doses:
2150, 681, 464, 215, 147 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
LD50-values were calculated using company software

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
313 mg/kg bw
95% CL:
229 - 427
Mortality:
147mg/kg bw: 1/10; 215mg/kg bw: 3 /10; 464mg/kg bw: 6/10; 681mg/kg bw: 10/10; 2150mg/kg bw: 10/10;
Clinical signs:
Dyspnea, apathy, staggering, tremors, piloerection, poor general state at all dose levels
Body weight:
All surviving animals gained weight
Gross pathology:
Animals that died: Heart: acute dilatation; acute passive hyperemia; stomach: hemorrhagic areas, in the forestomach in some animals ; scabbing
hemorrhagic gastritis in several animals; intestines: diffusely reddened mucosa in several animals; liver: peripheral acinar pattern sporadically
Sacrificed animals: Stomach: wall thickening at the tip of the forestomach; intraabdominal adhesion

Applicant's summary and conclusion